Author

Emanuela Galeazzi

Observed names: E Galeazzi, E. Galeazzi, GALEAZZI E., Galeazzi E

Institution: University of Turin

Observed institution: University of Turin

OpenAlex ID: A5062835814

Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases

2000 · Giorgio Cortesina, Tiziana Martone, et al. · International Journal of Cancer · 75

Interleukin‐2 injected around tumor‐draining lymph nodes in head and neck cancer

1991 · Giorgio Cortesina, Antonella De Stefani, et al. · Head & Neck · 61

Staging of head and neck squamous cell carcinoma using theMET oncogene product as marker of tumor cells in lymph node metastases

2000 · Giorgio Cortesina, Tiziana Martone, et al. · International Journal of Cancer · 55

Detection ofMET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas

1997 · E. Galeazzi, M. Olivero, et al. · European Archives of Oto-Rhino-Laryngology · 50

Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphatically

1994 · G Cortesina, A De Stefani, et al. · British Journal of Cancer · 47

Basic science reviews. Immunology of head and neck cancer: Perspectives

1993 · Norris K. Lee, Giorgio Cortesina, et al. · Head & Neck · 20

The Effect of Preoperative Local Interleukin-2 (IL-2) Injections in Patients with Head and Neck Squamous Cell Carcinoma: An Immunological Study

1991 · G. Cortesina, A. De Stefani, et al. · Acta Oto-Laryngologica · 20

Basic science reviews: Immunomodulation therapy for squamous cell carcinoma of the head and neck

1993 · Norris K. Lee, Giorgio Cortesina, et al. · Head & Neck · 16

Interleukin 2 Receptors on Squamous Cell Carcinomas of the Head and Neck

1992 · Giorgio Cortesina, Manuela Sacchi, et al. · Acta Oto-Laryngologica · 11

Immunological Investigations on Tonsillar and Peripheral Blood Lymphocytes after Adeno-tonsillectomy: Possible Suggestions for Phenotypical and Functional Differences

1991 · M. Bussi, M. T. Carlevato, et al. · Acta Oto-Laryngologica · 11

[Loco-regional treatment with low and high doses of interleukin-2 of head and neck squamous cell carcinoma recurrences].

1994 · G Cortesina, A De Stefani, et al. · PubMed · 7

The 11S and 7S IgA ratio in nasal secretions: An original method of determination

1991 · Mario Bussi, M. T. Carlevato, et al. · 2

[Local immunity following treatment with S-carboxymethylcysteine-lysine in tracheotomy patients].

1992 · M T Carlevato, S Battaglio, et al. · PubMed · 1

[Perilymphatic injection of interleukin-2 (IL-2) in recurrent squamous cell carcinoma of the head and neck].

1989 · G Cortesina, A De Stefani, et al. · PubMed · 1

Interleukin-2 and head and neck squamous cell carcinoma: Clinical and pathological studies

1992 · G. Cortesina, A. De Stefani, et al. · Pharmacological Research

[Antitumor activity of adherent LAK cells (A-LAK) in a model of squamous carcinoma of the head and neck].

1991 · M Sacchi, E Galeazzi, et al. · PubMed

[Determination of 11S IgA in nasal secretions in the monitoring of local immunomodulating therapy].

1991 · M Bussi, M T Carlevato, et al. · PubMed

[Determination of 11S IgA in nasal secretions in the monitoring of local immunomodulating therapy]. FT Il dosaggio delle IgA 11S nel secreto nasale nel monitoraggio delle terapie immunomodulanti locali.

1991 · BUSSI , MARIO, Carlevato M. T, et al. · Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele

[Perilymphatic injection of interleukin-2 (IL-2) in recurrent squamous cell carcinoma of the head and neck]

1989 · CORTESINA G., DE STEFANI A., et al. · Institutional Research Information System University of Turin (University of Turin)

Works count: 19

Citation count: 377

H-index: 10

I10-index: 10